Clinical Trials for mAbxience

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: mAbxience

Clinical Trials (2)

NCT06687369
A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Keytruda® in Non-small Cell Lung Cancer (BENITO Study)
PHASE3Recruiting
726 participants
Started: Dec 30, 2024 · Completed: Sep 30, 2027
1 condition1 sponsor18 locations
NCT06596772
A Study to Compare Efficacy, Pharmacokinetics, Safety and Immunogenicity of MB04 [proposed Etanercept Biosimilar] to Enbrel® [EU-sourced] in Rheumatoid Arthritis
PHASE3Recruiting
458 participants
Started: Oct 3, 2024 · Completed: Jan 31, 2026
1 condition1 sponsor60 locations